TM Owner Bausch & Lomb
Miebo 100% Eye Drops
Global Shipping : Reliable Global Distribution Network
Express Delivery : Priority Shipping for Every Order
Secure Payments : Trusted Payment Protection System
Disclaimer
Secure Handling
24/7 Worldwide Support
Global Access
Worldwide Access to Health
Cold-Chain Expert
Excellence in Cold-Chain
Trusted Supply
Certified Medical Supply
Indications & Clinical Uses
- Miebo (perfluorohexyloctane ophthalmic solution) 100% is approved in the United States for the treatment of the signs and symptoms of dry eye disease (DED) in adults.
- It is a preservative-free, water-free eye drop that works by forming a thin protective layer over the tear film to reduce excessive evaporation of tears, rather than by adding lubrication in the way traditional artificial tears do.
- It was approved by the FDA in May 2023 and is the first ophthalmic drop specifically approved to target tear evaporation as its mechanism of action.
- No EU/EMA marketing authorisation for Miebo under this brand name was found in the sources checked for this entry; availability outside the United States should be confirmed with a local regulator or pharmacist.
Side Effects
- There is no boxed warning for Miebo.
- The most common side effects, occurring in a small percentage of users, are blurred vision (reported in less than 4% of patients) and mild eye redness (conjunctival redness, in 1-3%).
- Most reactions are mild and temporary.
- Hypersensitivity reactions have also been reported in premarketing studies.
- Contact your healthcare provider if blurred vision or eye redness is severe, persistent, or worsening, or if you experience eye pain, significant vision changes, or signs of an allergic reaction such as eyelid swelling after using the drops.
Precautions & Warnings
- Do not use Miebo if you have a known hypersensitivity to perfluorohexyloctane.
- Remove contact lenses before instilling Miebo and wait at least 30 minutes before reinserting them, as the drop is not intended for use with lenses in place.
- Use only in the eye (ophthalmic use); do not inject or swallow it.
- If you use other eye drops, apply Miebo at least 5 minutes after any other topical eye medicine, as recommended for most eye drop combinations, and confirm the specific spacing with your healthcare provider.
- There is no specific pregnancy or breastfeeding restriction described in the current label, but tell your eye care provider about your full medical history, including any eye surgery, before starting.
Avoid Interactions
- No formal drug interaction studies are described on the current Miebo label, and it is not known to affect other medicines taken by mouth or injection, because it acts locally on the eye's tear film with minimal systemic absorption.
- Tell your eye care provider about all other eye drops, ointments, or gels you use, including artificial tears, since applying more than one eye product together can dilute or wash out either one; space other topical eye medicines several minutes apart from Miebo and confirm the exact order and timing with your pharmacist or prescriber, especially if you use more than one prescription eye drop.
References
Frequently Asked Questions
Miebo (perfluorohexyloctane) is a preservative-free eye drop approved in the US to treat the signs and symptoms of dry eye disease in adults. It works by forming a thin layer over your tears to reduce evaporation, rather than adding lubrication like traditional artificial tears.
Instill one drop of Miebo into each affected eye four times daily. Remove contact lenses before using it and wait at least 30 minutes before putting them back in, since Miebo is not meant to be used with lenses in place.
The most common side effects are blurred vision, affecting fewer than 4% of users, and mild eye redness, in 1-3%. These are usually temporary. Contact your eye care provider if blurred vision or redness is severe, doesn't improve, or you notice eye pain or swelling.
Avoid using Miebo while wearing contact lenses; remove them first and wait at least 30 minutes before reinserting. If you use other eye drops, space them several minutes apart from Miebo so one product doesn't wash out or dilute the other.
Store Miebo at 15°C to 25°C (59°F to 77°F). Once opened, the bottle can be used until the expiration date printed on it. Keep it out of reach of children, and always check the drop for damage before using it.
Miebo is used for ongoing management of dry eye disease, four times daily, for as long as your eye care provider recommends based on your symptoms. There is no set treatment length in the label; your provider reviews your response at follow-up visits.
Trusted & Reliable – Your Partner in Global Distribution.
We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.
